Application of protective one-lung ventilation strategy in neonates undergoing thoracoscopic assisted esophageal reconstruction

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100041950

Enrollment

Unknown

Registered

2021-01-10

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital esophageal atresia

Interventions

experimental group:Protective one-lung ventilation

control group:received pressure control double lung ventilation (P-DLV) during the operation

Eligibility

Sex/Gender

All

Age

No minimum to 1 Years

Inclusion criteria

Inclusion criteria: neonates with thoracoscopic reconstruction of esophagus.

Exclusion criteria

Exclusion criteria: 1.Patients with severe aspiration pneumonia need oxygen therapy before operation; 2.Very low birth weight (<1.5 kg); 3.Preoperative assessment of cardiopulmonary function, Can not tolerate OLV; 4.Non-III esophageal atresia; 5.Oesophageal tracheostomy was located near the protuberance; 6.The family of the child refused.

Design outcomes

Primary

Measure	Time frame
PaO2, PaCO2, pH;PIP?PETCO2;	—

Secondary

Measure	Time frame
HR?MAP;	—

Countries

China

Contacts

Public ContactYingying Sun

Anhui Provincial Children's Hospital

sunyy168@126.com+86 13866788117

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026